Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:

NCT ID: NCT03995576 Completed - Clinical trials for Thoracic; Sympathetic Ganglion, Injury

Thoracic Sympathetic Ganglion Block Inadvertent Spread

Start date: June 23, 2019
Phase:
Study type: Observational

This study wants to identify the incidence of inadvertend intercostal or epidural spread of thoracic sympathetic block

NCT ID: NCT03957707 Recruiting - Clinical trials for Basal Ganglia Haematoma

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

SOITBE
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Spontaneous cerebral hemorrhage is one of the main causes of death and disability all over the world, accounting for 20%-30% of all cerebrovascular diseases. Minimally invasive surgery of cerebral hemorrhage, especially puncture aspiration, can improve early and long-term neurological recovery in patients with cerebral hemorrhage. Until now, no standardized practice for minimally invasive surgery of spontaneous cerebral hemorrhage has been established. Hematoma puncture and drainage based on CT scans without precise localization and personalized approach design, which may lead to poor efficacy and high risk of complications. Our hospital has much experience in treating cerebral hemorrhage with stereotactic puncture and aspiration. So we conduct a prospective multicenter randomized controlled clinical trial to determine the therapeutic effects of puncture aspiration plus thrombolysis treatment for the perioperative and long-term recovery of patients with small to moderate hematoma in deep basal ganglia via computerized precision coordinates and personalized approach design.

NCT ID: NCT03944876 Recruiting - Cluster Headache Clinical Trials

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache

BASIC
Start date: November 1, 2019
Phase: Phase 3
Study type: Interventional

Cluster headache is a primary headache condition characterized by clusters of one-sided, high-intensity pain attacks. The headache may be episodic or chronic. Treatment options are limited and their effects unsatisfactory. An important nerve pathway involved in the pain attacks has a switching station at the sphenopalatine ganglion (SPG) located in the depth of the facial bones. SPG is a known therapy target for cluster headache. The area can be identified on CT images, but is difficult to access due to its location. Thus, the Multiguide navigation system has been developed to enable precise delivery of the drugs that target SPG activity. In Trondheim, two phase 1 / Phase 2 study have been carried out using botulinum toxin A (Botox®) against SPG in patient with chronic cluster headache and chronic migraine. The results indicate that such a treatment strategy is safe and beneficial. The current study is a randomized, placebo-controlled, triple-blinded study to investigate whether precise single-injection of botulinum toxin A reduces the frequency of attacks in chronic cluster headache .

NCT ID: NCT03902860 Completed - Clinical trials for Chronic Pain Requiring Stellate, Thoracic, and Lumbar Sympathetic Ganglia Blockade

Measurement of the Skin Sympathetic Nerve Activity During Stellate, Thoracic, and Lumbar Sympathetic Ganglia Block

Start date: May 15, 2019
Phase:
Study type: Observational

Sympathetic nerve activity can be measured transcutaneously in awake patients by computer-based filtering of raw signal obtained via skin leads attached on the chest and the right arm. Electrocardiogram can be removed by applying a high-pass filter setting of 150 Hz. Electromyogram can be filtered by applying a high-pass filter setting of 500 Hz or a band-pass filter setting of 500-1000 Hz. Currently, the therapeutic effect of stellate, thoracic, and lumbar sympathetic ganglia block (SGB, TSGB, and LSGB, respectively) in patients with chronic pain is generally evaluated by using thermogram/thermography (change in temperature of the upper or lower extremeties) or questionnaire-based scoring. However, it is not known whether the skin sympathetic nerve activity (SKNA) can be measured in patients undergoing SGB/TSGB/LSGB and used as an alternative tool for assessing the therapeutic effect of SGB/TSGB/LSGB. Therefore, we planned this pilot study to observe whether the SKNA can be obtained in patients undergoing SGB/TSGB/LSGB and whether it is well correlated to thermogram or questionnaire-based scoring. If the SKNA is observed and decreases after SGB/TSGB/LSGB, it will be presented in milivolt (uV) and compared to that of pre-block values.

NCT ID: NCT03889652 Completed - Cataract Clinical Trials

Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction

Start date: October 20, 2018
Phase:
Study type: Observational

Optical coherence tomography (OCT) for retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) is done before and after cataract extraction in patients with or without primary open angle glaucoma (POAG)

NCT ID: NCT03868449 Completed - Clinical trials for Carpal Tunnel Syndrome

Question Prompt List for Common Hand Conditions

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

Patients with common hand conditions will be randomized to one of two groups- one will receive a question prompt list, the other will receive a list of 3 questions

NCT ID: NCT03779958 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Alternatives to Hand Therapy for Hand Surgery Patients

Start date: January 12, 2019
Phase:
Study type: Observational

Patients will be asked to use a mobile phone app to conduct their hand therapy after having hand surgery.

NCT ID: NCT03756272 Completed - Postmenopausal Clinical Trials

Stellate Ganglion Block to Reduce Hot Flushes

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure

NCT ID: NCT03652714 Completed - Clinical trials for Postdural Puncture Headache

The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache

Start date: September 19, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.

NCT ID: NCT03512977 Completed - Clinical trials for Central Nervous System Diseases

Is Sphenopalatine Ganglion Block Treatment Effective on Postspinal Headaches

SPG
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

This study evaluates effect of sphenopalatine ganglion block in post dural puncture headache. Half of participants will receive standard supportive treatment and other half of patients will be performed sphenopalatine ganglion block.